Loss of p53 and activation of the Akt pathway is critical in promoting the glycolytic phenotype of cancer cells by stimulating, i) transcription and translation of GLUT1 glucose transporter in cancer models [32, 33] and ii) hexokinase activity and localization with the mitochondria. Here, SLC2A1 is linked to cancer.